The Latest
Durysta Approved for Open-Angle Glaucoma, Ocular Hypertension
Vibegron Under Review for Overactive Bladder Treatment
Survey: Management of Amikacin Liposome Inhalation Suspension-Associated Respiratory Adverse Events
Ketorolac Tromethamine Injection Recalled Due to Presence of Particulates
FDA Strengthens Warning About Risk of Neuropsychiatric Events With Montelukast
MPR Weekly Dose Podcast Episode 24
Short-Term Medications May Cut Risk for ‘Broken Heart’ Syndrome
Smartphone Use Linked to Increased Meds Required for Headache
HIV Therapy Symtuza Approved for Use in Pediatric Patients
MPR ARTICLES
